540359 PARMAX

Parmax Pharma Share Price

 

 

Start SIP in PARMAX

Start SIP

Performance

  • Low
  • ₹33
  • High
  • ₹35
  • 52 Week Low
  • ₹28
  • 52 Week High
  • ₹55
  • Open Price₹34
  • Previous Close₹34
  • Volume1,257

Smart Investing Starts Here Start SIP with Parmax Pharma for Steady Growth!

Invest Now

Parmax Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -2.7
  • PEG Ratio
  • 0.1
  • Market Cap Cr
  • 13
  • P/B Ratio
  • Average True Range
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • RSI
  • 55.47
  • MFI
  • 76.57

Parmax Pharma Financials

Parmax Pharma Technicals

EMA & SMA

Current Price
₹34.70
+ 0.91 (2.69%)
pointer
  • Bearish Moving Average 5
  • Bullish Moving Average 11

Ratings

Master Rating

EPS Strenth

N/A

Price Strength

Buyer Demand

Group Rank

Parmax Pharma has an operating revenue of Rs. 15.58 Cr. on a trailing 12-month basis. An annual revenue growth of 154% is outstanding, Pre-tax margin of -8% needs improvement, NULL From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 30 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C which is evident from recent supply seen, Group Rank of 71 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Parmax Pharma Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-14 Quarterly Results
2025-08-14 Quarterly Results
2025-05-30 Audited Results
2025-02-14 Quarterly Results
2024-11-14 Quarterly Results

Parmax Pharma F&O

Parmax Pharma Shareholding Pattern

30.8%
63.09%
6.11%

About Parmax Pharma

  • NSE Symbol
  • PARMAX
  • BSE Symbol
  • 540359
  • Managing Director
  • Dr. Umang Alkesh Gosalia
  • ISIN
  • INE240T01014

Similar Stocks to Parmax Pharma

Parmax Pharma FAQs

Parmax Pharma share price is ₹34 As on 05 December, 2025 | 05:36

The Market Cap of Parmax Pharma is ₹13 Cr As on 05 December, 2025 | 05:36

The P/E ratio of Parmax Pharma is -2.7 As on 05 December, 2025 | 05:36

The PB ratio of Parmax Pharma is -4.8 As on 05 December, 2025 | 05:36

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23